Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Approved for use in oncology care according to FDA-approved indications.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.